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DNA plasmids that express flavivirus premembrane/membrane (prM/M) and envelope (E) proteins in the form of virus-like particles
(VLPs) have an excellent potential as DNA vaccine candidates against virus infection. The plasmid-expressed VLPs are also useful as safe,
noninfectious antigens in serodiagnostic assays. We have constructed plasmids containing the prM/M and E gene regions for DENV-1, -3,
and -4 that express and secrete VLPs when electroporated into Chinese hamster ovary cells. Constructs containing the full-length DENV-1 E
protein gene did not secrete VLPs into tissue culture fluid effectively. However, a 16-fold increase in ELISA titers of DENV-1 VLPs was
achieved after replacing the carboxy-terminal 20% region of DENV-1 E protein gene with the corresponding sequence of Japanese
encephalitis virus (JEV). DENV-3 plasmids containing either the full-length DENV-3 E protein gene or the 20% JEV sequence replacement
secreted VLPs to similarly high levels. Whereas DENV-4 VLPs were secreted to high levels by plasmids containing the full-length DENV-4
E protein gene but not by the chimeric plasmid containing 20% JEV E replacement. Domain substitutions by replacing prM/M protein stem-
anchor region with the corresponding prM/M stem-anchor region of JEVor DENV-2 in the chimeric DENV-4 construct failed to promote the
secretion of DENV-4 VLPs. Using the DENV-2 chimeric plasmid with carboxy-terminal 10% of JEV E gene, the sequence responsible for
intracellular localization of E protein was mapped onto the E-H1 a-helix domain of DENV-2 E protein. Substitution of three amino acids
from the DENV-2 sequence to the corresponding amino acids in the JEV sequence (I398L, M401A, and M412L) in the E-H1 was sufficient
to promote extracellular secretion and resulted in detectable titers of DENV-2 VLP secretion.
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The genome of viruses in the genus Flavivirus of the
family Flaviviridae consists of ~11 kb single-stranded,
positive-sense RNA genome which encodes capsid (C),
premembrane/membrane (prM/M), and envelope (E) struc-
tural proteins, and seven nonstructural proteins (NS1, NS2A,
NS2B, NS3, NS4A, NS4B, and NS5). Signal sequences
located at the carboxy-terminal regions of C as well as prM/0042-6822/$ - see front matter. Published by Elsevier Inc.
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E-mail address: gxc7@cdc.gov (G.-J.J. Chang).M target prM/M and E structural proteins, respectively, for
translocation, transport, and secretion through the endoplas-
mic reticulum (ER) and Golgi apparatus. The prM/M and E
proteins are anchored to the ER membrane by their carboxy-
terminal domains and associate into heterodimers via
interactions between both the ectodomains and the car-
boxy-terminal stem-anchor regions of each protein (Allison
et al., 1999). The amino-terminus (or non-M region) of prM/
M prevents premature irreversible low-pH-induced confor-
mational changes in E protein during transit through acidic
exocytotic vesicles (Heinz et al., 1994) to ensure the release
of functionally active, fusion-competent virus. Structural
proteins are subsequently transported through the cell05) 239–250
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cellular furin or a furin-like protease just prior to the release
of virus particles from the cell (Stadler et al., 1997).
The prM/M stem region, represented by amino acids M-
23 to M-37 of dengue virus type 2 (DENV-2), consists of a
weakly amphipathic a-helix (M-H) which is partially buried
at its carboxy-terminus in the outer lipid leaflet of virion
particles, forming a ~208 angle with the lipid membrane
surface (Zhang et al., 2003). The two a-helical trans-
membrane domains (M-T1 and M-T2) of the prM/M anchor
region (amino acids M-40 to M-70) partially traverse the
lipid bilayer and form an antiparallel coiled-coil structure.
The E anchor region (amino acids E-452 to 491) is similar to
that of prM/M and consists of two transmembrane regions
(E-T1 and E-T2). The E stem region (amino acids E-395 to
450) consists of two consecutive mostly amphipathic a-
helices (E-H1 and E-H2) that are separated by the conserved
sequence (CS) element, a stretch of amino acids highly
conserved among flaviviruses (Stiasny et al., 1996). Similar
to M-H, both E-H1 and E-H2 are also partially buried in the
outer lipid bilayer (Zhang et al., 2003).
Potential functions for the E protein stem and anchor
elements of tick-borne encephalitis virus (TBEV), a member
of the Flavivirus, were determined based on truncation of
each domain and assaying for secretion of prM and E
proteins in VLP form (Allison et al., 1999). The E-T2
transmembrane domain, the signal sequence for NS1, is
dispensable for the incorporation of E protein into VLPs,
whereas E-T1 acts as a membrane anchor and is required for
the incorporation of E proteins into VLPs. Stabilization of
prM-E heterodimers is conferred by the E-H2 helix,
possibly in conjunction with E-T1, although studies of
yellow fever virus (YFV) support the speculation that the
transmembrane domains of flaviviruses affect the formation
of virus but not by prM-E heterodimerization (Op De Beeck
et al., 2003). The E-H1 a-helix is involved in irreversible
trimerization of soluble E proteins upon exposure to low pH
environments (Allison et al., 1999).
During natural flavivirus infections, noninfectious,
empty virus-like particles (VLPs) are produced in addition
to infectious, mature virions (Russell et al., 1980). These
VLPs have structural and physiochemical properties similar
to mature virions. Thus, plasmid constructs capable of
expressing prM/M- and E-containing VLPs have been the
subject of intensive study for their potential as DNA vaccine
candidates and as expression plasmids for producing non-
infectious serodiagnostic antigens and biosynthetic subunit
vaccine candidates. Previously, we reported that pCDJE2-7
and pCBWN plasmid-transformed COS-1 cells express and
secrete JEV and WNV VLPs, respectively, into the tissue
culture media (Chang et al., 2000; Davis et al., 2001; Hunt
et al., 2001). Plasmid DNA containing a eukaryotic
transcriptional unit consisting of the human cytomegalovi-
rus immediate early gene promoter, Kozak consensus
ribosomal binding sequence, JEV signal sequence located
at the carboxy-terminus of C protein, and full-length prM/Mand E gene regions of JEV or WNV is sufficient for
production of VLPs. More recently, we successfully
constructed similar expression vectors for the expression
of DENV-2 and St. Louis encephalitis virus (SLEV) prM/M
and E proteins (Chang et al., 2003; Purdy et al., 2004).
Signal peptidase cleavage at the C-prM junction of the
flavivirus polypeptide precursor is dependent on prior
processing of the upstream C protein sequence by the viral
NS2B/NS3 serine protease to expose the cryptic cleavage
site for efficient processing (Stocks and Lobigs, 1998). To
eliminate the requirement of NS2B/NS3 for efficient
processing, we have incorporated the optimized JEV signal
sequence (Chang et al., 2001) into WNV, DENV-2, and
SLEV constructs. However, secretion of either DENV-2 or
SLEV VLPs from tissue culture cells could be achieved
only by constructing chimeric plasmids having an additional
replacement of the carboxy-terminal 20% of E protein with
the corresponding region derived from JEV. The E protein
stem-anchor region of DENV-2 and SLEV may therefore
contain a peptide sequence which prevents efficient trans-
port of E protein through the cell secretory network; and
replacement with the JEV stem-anchor could alleviate such
retention. The region involved is suspected to be localized
between amino acids E-397 and E-436 in the DENV-2 E
protein, the region corresponding to the E-H1 and E-H2
stem a-helices, since the DENV-2 construct having replace-
ment of the carboxy-terminal 10% of E protein with the
corresponding E-T1 and E-T2 domains of JEValone did not
improve VLP secretion (Chang et al., 2003).
Based on these previous findings with DENV-2, we
attempted to construct DENV-1, DENV-3, and DENV-4
chimeric plasmids for the expression of viral structural
proteins in tissue culture and the secretion of VLPs. To
further investigate the E protein region affecting retention
and secretion, we mutated 13 amino acids in the E-H1 and
E-H2 stem region of the pCB9D2-1J-4-3, a non-secreting
plasmid constructed in our previous study (Chang et al.,
2003) which consists of the 90% amino-terminal and 10%
carboxy-terminal E protein regions of DENV-2 and JEV,
respectively, and assayed for the ability of individual or
combined mutations that may improve VLP secretion. We
describe herein the expression of DENV-1, -3, and -4 prM/
M- and E-containing VLPs, and further investigate the
important roles of amino acids in a-helix E-H1 of the stem
region of DENV-2 E protein that affect intracellular
retention and secretion of VLPs.Results
Transient expression of chimeric DENV VLPs
We previously reported that VLPs, which consist of
DENV prM, M, and E proteins and which do not contain
any C protein, were secreted from transformed COS-1 cells
only after replacement of the carboxy-terminal 20% of
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JEV (Chang et al., 2003). However, VLPs were not secreted
by the plasmids with the full-length DENV-2 E protein or
with replacement of only the carboxy-terminal 10%.
Experiments to construct similar expression plasmids for
DENV-1, -3, and -4 were therefore designed based on this
carboxy-terminal 20% replacement of the DENV E protein
stem-anchor region with the corresponding JEV region (Fig.
1). All constructs expressed E protein in plasmid-trans-
formed CHO cells, as detected by IFA using flavivirus
group-reactive MAb (4G2) specific for E protein. However,
we observed a variation in staining intensity and morpho-
logical pattern depending upon plasmid constructs (Table 1).
As expected, expression plasmids pCB8D1-2J and
pCB8D3-2J both efficiently secreted DENV-1 and -3 VLPs
from transformed CHO cells, respectively, with Ag-ELISA
endpoint titers of 1:32 (Table 1). Conversely, the pCB8D4-
2J plasmid-transformed cells only secrete DENV-4 VLPs
with Ag-ELISA endpoint titers V1:4.
Interactions between the stem-anchor regions of prM/M
and E proteins contribute to overall virus particle stability;
thus, suboptimal interactions between the DENV-4 prM/M
and JEV E protein stem-anchor regions may have prevented
the efficient secretion of chimeric DENV-4 VLPs by
pCB8D4-2J. In order to mimic the interactions between
these regions previously shown to be associated with
efficient secretion of JEV and DENV-2 VLPs, the prM/MFig. 1. Comparison of flavivirus premembrane/membrane (prM/M) and envelope
an optimized Japanese encephalitis virus signal sequence (JESS) and viral prM/M
stem a-helical (H; cross-hatched boxes) and transmembrane coiled-coil (T; shad
terminal 10% and 20% E protein regions contain amino acids E-442 to E-495 an
primary amino acid sequences with Japanese encephalitis virus (JEV) or dengue vi
or DENV-4 sequence are indicated by dots; the single amino acid code is given for
of prM/M and E proteins, determined by secondary structure prediction from thestem-anchor region of pCB8D4-2J, containing the three a-
helical domains M-H, M-T1, and M-T2 (Fig. 1) of DENV-4
was replaced with that of either DENV-2 or JEV (designated
as pCBD2prM8D4-2J or pCBJprM8D4-2J, respectively).
Contrary to our expectation, these replacements actually
reduced secretion to undetectable levels. Additionally, cells
transformed with either the DENV-2 or JEV prM/M protein
stem-anchor replacement construct appeared to accumulate
E protein in perinuclear regions of transformed cells (data
not shown). Conversion of the remaining three amino acids
outside of three helical domains of pCBD2prM8D4-2J to
the authentic M protein sequence of DENV-2 (designated as
pCBD2M8D4-2J) still did not enhance VLP secretion.
These results indicated that interactions other than those
between the prM/M-E stem-anchor regions were important
in the secretion of chimeric DENV-4 VLPs.
Since JEV and WNV VLPs can be expressed efficiently
in plasmids containing full-length JEV and WNV prM/M
and E proteins, respectively (Chang et al., 2000; Davis et al.,
2001), the expression plasmid containing the full-length
prM/M and E protein genes of DENV-4 (Sri Lanka) was
constructed. In addition, the plasmid containing the full-
length prM and E genes of DENV-4 (Honduras) was
constructed to determine if strain-specificity sequence
played a role in secretion of VLPs. CHO cells transformed
with both full-length prM and E of DENV-4 constructs
secreted VLPs at Ag-ELISA endpoint titers of 1:32(E) protein stem-anchor regions. (A) Flavivirus expression cassettes contain
and E gene regions for efficient expression of virus structural proteins. The
ed boxes) domains for each structural protein are indicated. The carboxy-
d E-397 to E-495, respectively. (B) Alignment of flavivirus E and prM/M
rus type 4 (DENV-4) sequences, respectively. Residues identical to the JEV
variant residues. The stem a-helical and transmembrane coiled-coil domains
primary amino acid sequence, are indicated by solid bars.
Table 1
VLP secretion titers for DENV plasmid-transformed CHO cells
Plasmid Virus (strain) Chimeric region IFA pattern Ag-ELISA
titer
pCB8D1-2J DENV-1 (Panama 1994) 20% JEV-E Diffuse 32
pCBD1 DENV-1 (Panama 1994) – Diffuse 2
pCB8D2-2J-2-9-1 DENV-2 (16681) 20% JEV-E Diffuse 64
pCB9D2-1J-4-3 DENV-2 (16681) 10% JEV-E Globular 0
pCBD2-14-6 DEBN-2 (16681) – Globular 0
pCB8D3-2J DENV-3 (Panama 1994) 20% JEV-E Diffuse 32
pCBD3 DENV-3 (Panama 1994) – Diffuse 32
pCB8D4-2J DENV-4 (Sri Lanka 1994) 20% JEV-E Diffuse 4
pCBD4 DENV-4 (Sri Lanka 1994) – Diffuse 32
pCB8D4-2J-H DENV-4 (Honduras 1994) 20% JEV-E Diffuse 4
pCBD4-H DENV-4 (Honduras 1994) – Diffuse 32
pCBD2prM8D4-2J DENV-4 (Sri Lanka 1994) 20% JEV-E DENV-2 M-H, T1, T2 Globular 0
pCBD2M8D4-2J DENV-4 (Sri Lanka 1994) 20% JEV-E DENV-2 M Globular 0
pCBJprM8D4-2J DENV-4 (Sri Lanka 1994) 20% JEV-E JEV M-H, T1, T2 Globular 0
D.E. Purdy, G.-J.J. Chang / Virology 333 (2005) 239–250242(Table 1). This unexpected result prompted us to construct
expression plasmids containing the full-length DENV-1 and
-3 prM and E protein genes (designated as pCBD1 and
pCBD3, respectively) in order to understand the affect of the
E protein stem-anchor region on VLP extracellular release
for each DENV serotype. As observed previously for
DENV-2 plasmids containing the full-length prM and E
genes, the VLP secretion was significantly reduced by the
pCBD1, with Ag-ELISA titers 16-fold lower than those for
pCB8D1-2J. Surprisingly, however, pCBD3 secreted VLPs
at Ag-ELISA titers similar to those for pCB8D3-2J. These
results suggest that replacement of the carboxy-terminal
20% of DENV E protein with that of JEV provides for
proper assembly and secretion of VLPs for DENV-1 and -2,
yet does not produce any additional benefit to promote
DENV-3 VLP secretion, and actually adversely affects the
secretion of DENV-4 VLPs.
Characterization of DENV VLPs
The protein compositions of the VLP preparations
expressed by constructs pCB8D1-2J, pCB8D2-2J-2-9-1,
pCB8D3-2J, and pCBD4 were analyzed by Western blot
(Fig. 2) and compared to the corresponding gradient-
purified virions. As expected, the appropriate HIAF-
detected protein bands corresponding to the Mr for DENV
prM and E proteins (~20 and 55 kDa, respectively) in VLP
and purified virus preparations for each DENV serotype
(Fig. 2A). Bands corresponding to C protein were detected
in purified virus preparations for DENV-1 and -3 using the
appropriate HIAF while C protein was not detected for
either DENV-2 or -4. This may be due to a paucity of
antibodies with adequate avidity to bind C protein in the
HIAF preparations for DENV-2 and -4. This explanation
was supported by the follow-up experiment that the C
protein in the same preparation of purified DENV-2 virions
was detected by C-specific MAb 1A2A-1 (Fig. 2B). The C
protein was not detected in any VLP preparation since the
expression plasmids do not contain C protein-encodingsequence. In order to determine the identity of proteins
detected by HIAF, DENV-2 VLP and purified virus particle
preparations were analyzed with antibodies specific for
DENV-2 structural proteins (Fig. 2B). Bands with correct
sizes were detected in the DENV-2 VLPs when blotted
proteins on the membrane were reacted with a flavivirus E-
specific MAb (4G2), prM-specific MAb (2H2), and both
prM- and M-reactive antipeptide (M aa 1–34) serum. As
expected, C-specific MAb (1A2A-1) detected an appropri-
ately-sized band in purified virion but not in the VLP
preparation. Non-specific binding was not detected with any
antibody preparation when reacted with normal cell culture
antigen prepared identically to VLPs. Additionally, MAb
(4G2) detected a band corresponding to the Mr of E protein
in VLP preparations for all four DENV serotype constructs
(data not shown). These results indicated that DENV prM,
M, and E structural proteins were secreted into the tissue
culture fluid of plasmid-transformed CHO cells, most likely
in the form of VLPs.
Determination of minimal amino acid substitutions required
for secretion of chimeric DENV-2 VLPs
We previously reported that neither pCBD2-14-6 nor
pCB9D2-1J-4-3 constructs, containing the full-length
DENV-2 E or chimeric 90% DENV-2 E-10% JEV E protein
gene, respectively, secreted VLPs into tissue culture
medium whereas secretion was observed for the 80%
DENV-2 E-20% JEV E construct, pCB8D2-2J-2-9-1
(Chang et al., 2003). The carboxy-terminal 20% of
flavivirus E protein corresponds to the E-H1, CS, E-H2,
E-T1, and E-T2 elements, whereas the carboxy-terminal
10% region corresponds to the carboxy-terminus of E-H2 in
addition to the E-T1 and E-T2 domains (Fig. 1). We
speculated that the sequence located between amino acids
E-397 and E-436 of DENV-2 E protein, corresponding to
the E-H1 and E-H2 a-helical domains of the stem region,
was responsible for the accumulation of DENV-2 E proteins
in the perinuclear region of transformed cells and thus
Fig. 2. Characterization of dengue virus (DENV) extracellular virus-like
particles (VLPs) and virions. The first lane of each panel contains the
SeeBlue Plus2 pre-stained protein standard. Bands corresponding to
envelope (E), premembrane (prM), capsid (C), and cleaved membrane
(M) structural proteins are indicated with arrows to the right. (A) Reactivity
of pelleted VLPs and purified virion particles (V) for each DENV serotype
with mouse hyperimmune ascitic fluid for DENV-1 (Hawaii), DENV-2
(New Guinea C), DENV-3 (H-87), and DENV-4 (H-241). Mouse hyper-
immune ascitic fluid for DENV-1 (Hawaii) with pelleted normal cell culture
antigen from tissue culture fluid (CA) is representative of the lack of
reaction for all antibody preparations. (B) Reactivity of DENV-2 VLP and
virions with flavivirus group reactive, E-specific MAb (4G2), prM specific
MAb (2H2), antipeptide (M protein aa 1–34) serum reacted with DENV-2
prM/M protein, and C specific MAb (1A2A-1).
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amino acids, or combinations thereof, in the stem region that
affect this retention of DENV-2 E protein, we substituted by
site-directed mutagenesis the 13 amino acids of DENV-2
origin in the pCB9D2-1J-4-3 individually or in pairs with
the corresponding JEV sequence (Fig. 3). Most amino acid
substitutions did not result in an increase of VLP secretion
to detectable levels (data not shown). However, three amino
acid substitutions, I398L, M401A, and M412L, in the E-H1
a-helix increased secretion of VLPs to approximately 0.5%,
17%, and 6%, respectively, of titers for that of plasmid
pCB8D2-2J-2-9-1 (Fig. 4). Constructs containing the double
(I398L-M401A) or triple (I398L-M401A-M412L) substitu-
tions further enhanced VLP secretion compared with those
containing a single substitution. The Ag-ELISA titers for
double and triple substitutions rose to 25% and 50% of
pCBD8D2-2J-2-9-1, respectively. Secondary structure pre-
dictions based upon the primary amino acid sequences ofDENV-2 and JEV indicated that these three amino acids
were located in the hydrophobic face of the amphipathic E-
H1 a-helix (Fig. 5).
Localization of DENV structural proteins in CHO cells
Indirect immunofluorescence assay (IFA) analysis of
tissue culture cells transformed with DENV expression
plasmids revealed two types of fluorescent staining patterns;
diffuse low intensity staining with speckling throughout the
entire cell or globular high intensity staining localized to
perinuclear regions in the cell cytoplasm. The globular
pattern was observed in cells transformed with pCBD2-14-6
and pCB9D2-1J-4-3 (Chang et al., 2003, Figs. 6A and C,
respectively), as well as with the Q400K and L425I mutants
(Figs. 6B and D, respectively), that did not secrete VLPs to
detectable Ag-ELISA titers. The diffuse speckled staining
pattern was seen in cells transformed with secretion-
competent pCB8D2-2J-2-9-1, I398L, M401A, M412L,
and triple mutation plasmids. Fig. 6 shows representative
cells displaying this fluorescent staining pattern for
pCB8D2-2J-2-9-1 and the M401A mutant (Figs. 6E and F,
respectively). These results indicated that reduced VLP
secretion was most likely due to accumulation of a
significant amount of prM/M and/or E proteins in globular
clusters within the cell, whereas a more diffuse distribution
of proteins that was observed in the cytoplasm of cells that
secreted VLPs probably reflected lack of such an accumu-
lation or conversely more secretion.Discussion
In order to provide a simple method for producing VLPs
for all four DENV serotypes, expression plasmids pCB8D1-
2J, pCB8D3-2J, and pCBD4 were constructed for the
extracellular secretion of DENV-1, -3, and -4 VLPs,
respectively, using CHO cells in a method similar to that
described previously for DENV-2 (Chang et al., 2003).
Indirect immunofluorescence assays using a conformation-
dependent MAb (4G2) detected intracellular expression of
properly-folded E protein in the cells transformed with
expression plasmids for four DENV serotypes. Western blot
examination of pelleted VLPs with DENV HIAF revealed
protein bands corresponding in size to native virus prM and
E proteins for all respective viruses. A panel of antibodies
specific to each of the three structural proteins detected the
presence of the prM, M (processed prM), and E protein in
DENV-2 VLP preparations. These results, in addition to the
epitope mapping obtained from previously published results
in DENV-2 VLP expression study (Chang et al., 2003) and
electron microscope visualization of extracellular recombi-
nant particulate antigen of JEV (Hunt 2001), supported the
conclusion that DENV prM and E proteins were expressed
in proper conformation in CHO cells, that prM was cleaved
to M protein to some extent, and that these structural
Fig. 3. Schematic presentation of DENV-2 E protein stem region mutants. Mutations in the E-H1 and E-H2 domains (solid bars; approximately aa 398–415 and
425–447, respectively) of the non-secreting pCB9D2-1J-4-3 construct were made to convert the DENV-2 sequence to the corresponding JEV sequence in order
to identify the amino acid(s) affecting secretion of VLPs. Mutant constructs were named based on the amino acid substitution and position. Residues identical
to the pCB9D2-1J-4-3 sequence are indicated by dots and the single amino acid code is given for variant residues within each mutant construct. The efficiently-
secreting pCB8D2-2J-2-9-1 construct contains the 20% C-terminal JEV E protein replacement.
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resembling virion particles.
The VLPs were not efficiently secreted from cells
transformed with DENV-4 chimeric plasmid containing
replacement of the carboxy-terminal 20% of JEV E protein.
The interactions between the prM/M and E protein stem-
anchor regions were not involved in improving the
efficiency of VLP secretion. Replacement of DENV-4Fig. 4. Effect of E-H1 mutagenesis on secretion of chimeric DENV-2 VLPs.
Mutations in the E-H1 domain of pCB9D2-1J-4-3 that resulted in detectable
levels of antigen secretion were compared to the secretion of pCB8D2-2J-2-
9-1. Relative VLP secretion of each construct, taking that of pCB8D2-2J-2-
9-1 as 100%, was calculated for Ag-ELISA endpoint titers from three
independent experiments. The Ag-ELISA end-point titers were 64, 0, 4, 16,
and 32 for pCB8D2-2J-2-9-1, pCB9D2-1J-4-3, M412L, I398L-M410A,
and I398L-M401A-M412L constructs, respectively, in three separate
experiments. The Ag-ELISA end-point titers were 0, 0, and 1 for I398L,
and were 16, 8, and 8 for M401A constructs.prM/M stem-anchor region of DENV-2 or JEV in an attempt
to re-establish potentially important homologous prM/M-E
stem-anchor interactions failed to improve DENV-4 VLP
secretion. These results suggest that interactions in addition
to those between the prM/M and E stem-anchor regions are
important for efficient secretion of VLPs.
Previous results demonstrated that replacement of the
carboxy-terminal 10% of DENV-2 E protein, containing the
carboxy-terminus of E-H2 in addition to the E-T1 and E-T2
domains, with that of JEV sequence in the pCB9D2-1J-4-3
plasmid was unable to secrete detectable levels of VLPs
(Chang et al., 2003). Substitution of three DENV-2 amino
acids in this plasmid with the corresponding JEV sequence
in a-helix E-H1 resulted in the secretion of DENV-2 VLPs.
These results strongly implicate that the E-H1 domain,
particularly amino acids 398, 401, and 412, is involved in
intracellular retention/secretion of E protein, presumably at
the endoplasmic reticulum membrane of transformed cells.
The mechanism for this retention is unclear. However,
epitope mapping using a panel of MAbs did not detect any
significant differences in the epitopes expressed by the
intracellular E protein (Chang et al., 2003), ruling out the
possibility that retention is caused by misfolding of the
ectodomain of E. Without concurrent expression of viral
nucleocapsid to provide similar interactions during virion
assembly, the DENV-2 residues at I398, M401, and M412,
under this expression condition, may influence the proper
intra- or intermolecular interactions necessary for the
assembly and transport of prM- and E-containing VLPs
through the cell secretory machinery and hence for efficient
VLP secretion.
I398, M401, and M412 residues are distributed along the
hydrophobic face of the E-H1 a-helix that is partially buried
in the outer leaflet of the lipid membrane (Zhang et al.,
2003). An increase in the hydrophobicity of the residues at
Fig. 5. Comparison of DENV-2 and JEV E-H1 secondary structure arrangements. Helical wheel diagrams representing the E-H1 domains (approximately aa
398-415) for DENV-2 and JEV were constructed using the primary amino acid sequences of pCB9D2-1J-4-3 and pCB8D2-2J-2-9-1, respectively. The strong
amphipathic nature of these a-helices is apparent in the segregation of strongly or moderately hydrophobic (red and brown, respectively) and polar or charged
(black and blue, respectively) amino acids to distinctly separate faces of the helix. Mutations I398L, M401A, and M412L are localized to a similar region of the
hydrophobic face of the helix and are approximately aligned with each other along the hydrophobic face. 
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correlated with a significant increase in DENV-2 VLP
secretion, possibly as a result of proper burial of these
hydrophobic residues within the lipid membrane. Addition-
ally, shortening of the R-group side-chain length in
substitution M401A, and to a lesser extent in M412L,
may have increased the flexibility of the E-H1 a-helix with
regard to the pitch of the helix with the surface of the
membrane, thus allowing a wider range of flexibility of
amino acids on the hydrophilic face to interact with ecto-
domain of E protein. In either case, alterations in the
orientation of the hydrophobic face would consequently
affect the orientation of the entire helix, including the
hydrophilic face of the a-helix. Polar residues on this face
may require precise orientation to interact with the under-
side of the E protein ectodomain domains in E or even prM/
M proteins; the two E-H1 domains in E-E homodimers are
each located near the E-dimer bholeQ region where prM/M is
proposed to be located (Zhang et al., 2003). Several polar
and charged residues on this a-helix are potentially
available for intra- or intermolecular interactions. Addition-
ally, the E-H1 polar face includes a single hydrophobic
residue at position 415 that may influence protein inter-
actions by necessitating sequestration from solvent exposure
through burial in a hydrophobic pocket. Optimal interac-
tions formed within these regions through modification of
the E-H1 domain might in turn influence the curving and
bending of the lipid membrane, thereby resulting in the
assembly and release of VLPs (Garoff et al., 1998). Similar
interactions between the unmodified E-H1 and other
domains in the prM and E, resulting in the curving and
bending of the lipid membrane, could be provided by the
interactions between concurrently expressed nucleocapsid
and prM-E during virion assembly in natural viral infection.
As observed previously for DENV-2 and SLEV ex-
pression plasmids (Chang et al., 2003; Purdy et al., 2004),VLPs were only secreted to high Ag-ELISA titers after
replacement of the carboxy-terminal 20% of the DENV-1 E
protein with the corresponding region of JEV. DENV-3
VLPs were secreted equally well with or without the
replacement, whereas this replacement actually reduced
the secretion of DENV-4 VLPs 8-fold as compared to the
full-length DENV-4 E protein construct. The precise
interactions within this stem-anchor region of E protein that
affect intermolecular prM-E and E-E interactions and
efficient secretion of VLPs in this expression system may
vary between flaviviruses and remain to be conclusively
defined. It was apparent that amino acids 398, 401, and 412
played a significant role in the secretion of DENV-2 VLPs;
however, constructs containing all three JEV substitutions
only secreted VLPs to 50% the levels of the construct with
the complete E-H1 JEV sequence. These three residues are
highly conserved between the DENV group, yet substitution
of these residues with the replacement of the entire carboxy-
terminal 20% of E protein affected secretion to varying
degrees for each of the four serotypes. These three residues
influenced VLP secretion in DENV-2, and presumably
DENV-1 constructs but not in DENV-3 or -4 constructs.
Elucidation of the structural features determining assem-
bly, maturation, secretion, and membrane fusion of flavivi-
ruses is applicable to antiflaviviral drug development.
Identification of a DENV-2 E protein hydrophobic pocket,
proposed to be a hinge point for conformational changes
during membrane fusion, suggested that insertion of small
compounds into this pocket might inhibit the fusion
transition process and thus inhibit viral infection (Modis et
al., 2003). Modis et al. also suggested that peptides derived
from the stem sequences could interact with elements in E
protein clusters formed during transition to fusion stage,
thereby inhibiting the completion of membrane fusion
(Modis et al., 2004). We identified here three amino acids
in stem helix E-H1 that are involved in VLP secretion; thus,
Fig. 6. Comparison of immunofluorescence staining morphologies for
secreting and non-secreting plasmid-transformed CHO cells. Rabbit sera
containing antibodies against DENV-2 prM, M, and E proteins was used to
detect the expression and localization of viral structural proteins in CHO
cells transformed with expression plasmids. This rabbit serum was specific
for DENV proteins and did not react with normal CHO cell control (data
not showed). High-intensity globular expression patterns localized to
perinuclear regions in the cytoplasm were representative of retention of
structural proteins observed for pCBD2-14-6 (A), pCB9D2-1J-4-3 (C), and
for the majority of amino acid substitutions in the E-H1 and E-H2 stem
region, represented here by the Q400K (B) and L425I (D) mutant
constructs. A low-intensity diffuse staining pattern with specks of
concentrated structural proteins was observed throughout the cytoplasm
of cells transformed with pCB8D2-2J-2-9-1 (E) and other secretion-
competent mutants, represented here by the M401A (F) mutant construct.
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antiviral drug development.
The transformation of tissue culture cells with plasmid
DNA is advantageous for antigen production since these
cells secrete viral prM and E proteins in VLPs having proper
conformation and presentation of neutralizing-antibody
epitopes similar to those of virion particles (Chang et al.,
2000, 2003; Davis et al., 2001; Hunt et al., 2001; Konishi
and Fujii, 2002; Kroeger and McMinn, 2002; Schalich et al.,
1996). These VLP antigens are excellent alternatives to
virus-infected suckling mouse brain or tissue culture-
derived antigens for use in serodiagnostic assays. Indetecting antiflaviviral antibodies in human serum, ELISAs
employing WNV, JEV, and SLEV VLP antigens have
comparable sensitivities and specificities to those using
suckling mouse brain-derived antigens (Davis et al., 2001;
Hunt et al., 2001; Purdy et al., 2004). We have obtained
similar results in detecting IgM antibody of DENV patient
serum panels with the VLP antigens described here (D.A.
Holmes, D.E. Purdy, A.J. Noga, and G.J. Chang, submitted
for publication).
Expression plasmids encoding prM and E proteins of
flaviviruses have excellent potential as DNA vaccine
candidates. Plasmids for JEV, WNV, and DENV-2 that
secrete VLPs efficiently in tissue culture also elicit
neutralizing antibodies and provide protection against virus
challenge in mice (Chang et al., 2000, 2003; Davis et al.,
2001). Efficient secretion of VLPs in tissue culture might be
indicative of efficient VLP production in DNA-vaccinated
hosts. Thus, it is considered an important prerequisite for the
development of an adequate immune response with neu-
tralizing antibodies to protect vaccinated hosts against virus
challenge (Aberle et al., 1999; Chang et al., 2003). In
addition to the DENV-2 plasmid, pCB8D2-2J-2-9-1, con-
structed in a previous study, our current results indicate that
expression plasmids pCB8D1-2J, pCB8D3-2J, and pCBD4
express DENV-1, -3, and -4 VLPs efficiently, respectively,
thus these four DENV serotypes plasmids could be excellent
DNA vaccine candidates for eliciting neutralizing anti-
bodies. We are currently evaluating the immunological
responses of these vaccine candidates singly or in combi-
nation in mice.Materials and methods
Cell culture and virus strains
Chinese hamster ovary (CHO-K1) cells (CCL-61; ATCC,
Manassas, VA) were grown in Dulbecco’s modified Eagle
medium (D-MEM)/F12 (Gibco Laboratories, Grand Island,
NY) and C6/36 mosquito cells were grown in D-MEM
(Gibco Laboratories). All media were supplemented with
10% heat-inactivated fetal bovine serum (HyClone Labo-
ratories, Inc., Logan, UT), 1 mM sodium pyruvate, 1 mM
sodium glutamate, 0.1 mM MEM nonessential amino acids,
penicillin (100 U/ml), and 100 Ag/ml streptomycin. CHO
cells were incubated at 37 8C with 5% CO2 and Aedes
albopictus-derived C6/36 cells were maintained at 28 8C
without CO2.
The DENV-1, DENV-3, and DENV-4 strains listed in
Table 1 were propagated in C6/36 mosquito cell culture and
used for RNA extraction, reverse transcriptase-PCR (RT-
PCR), cDNA cloning, and protein analysis. For use in the
Western blot, virus was purified by precipitation with 7%
PEG-8000 (Fisher Scientific, Fair Lawn, NJ), followed by
ultracentrifugation on 30% glycerol–45% potassium tartrate
gradients (Obijeski et al., 1976).
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Expression plasmids were constructed for each of three
DENV serotypes (DENV-1, -3, and -4) by inserting a gene
cassette containing the respective DENV serotype full-
length prM/M and chimeric E protein gene, consisting of the
amino-terminal 80% region of DENV E protein gene and
the carboxy-terminal 20% region of JEV E protein gene,
into pCBJESS-AfeI vector. This pCBJESS-AfeI vector was
modified from the pCBJESS plasmid (Davis et al., 2001) by
introducing a unique AfeI cloning site at the carboxy-
terminus of the signal peptide sequence for the convenience
of cloning as well as for improvement of the cleavage
potential of the original JEV-encoded signal peptide
sequence (Chang et al., 2000; Davis et al., 2001). The
predicted signal peptide probability was significantly
improved by altering the cleavage region of the JEV signal
peptide sequence at -4 (C) and -2 (G) positions to G and S,
respectively, in the pCBJESS-AfeI plasmid (Chang et al.,
2001).
Briefly, the QIAamp Viral RNA kit (QIAGEN Inc.,
Valencia, CA) was used according to the manufacturer’s
recommended procedure to extract genomic RNA from 140
Al of virus-infected C6/36 cell-culture supernatant.
Extracted RNA was used as template for production of
cDNA encoding the DENV prM/M and amino-terminalTable 2
Oligonucleotides used for cloning of 100% and 80% DENV prM-E gene regions
Construct and primer Oligonuc
pCB8D1-2J
D1E-AfeI 5V CTTG
cD1E-StuI 5V TTGA
pCBD1
D1-AfeI-405 5V CTGG
cD1-NotI-2387 5V CGAG
pCB8D3-2J
D3E-AfeI 5V CTTG
cD3E-StuI 5V TTGA
pCBD3
D3-AfeI-405 5V CTTG
cD3-NotI-2387 5V CATG
pCB8D4-2J
D4E-AfeI 5V CTTG
cD4E-StuI 5V TTGA
pCBD4
D4-438 5V GCTT
cD4-NotI-2402 5V CATG
pCBD2prM8D4-2J, pCBJprM8D4-2J,
or pCBD2M8D4-2J
D4-KpnI 5V TAAC
cD4-EarI 5V CTCC
D2-EarI 5V GATG
cD2-BsaI 5V ATTC
J-EarI 5V GCTG
cJ-BsaI 5V ATTC
D4-BsaI 5V AATG
cD4-1151 5V TCCG
a Restriction endonuclease sites are indicated by bold, italicized, and underlined80% E protein gene by QIAGEN OneStep RT-PCR kit
(QIAGEN Inc.). Primer sequences containing the appro-
priate restriction enzyme sites for cloning (Table 2) were
designed based on the virus sequences (G.J. Chang,
unpublished data). The pCDJE2-7 plasmid (Chang et al.,
2000) was used as the PCR template to amplify the JEV
carboxy-terminal 20% E protein cDNA sequence using
primers J-StuI (5VGGAATTAGGCCTGGAAGCACGCTG
GGCAAGG) and cSP6 (5VGCGAGCTCTAGCATTTAGG-
TGACACTATAG). The PCR products for the DENV prM/
M-80% E and the JEV 20% E protein-encoding sequences
were digested with StuI and ligated together. Ligation
products were then PCR amplified with primers T7 and
cSP6. These amplicons were sequentially digested with
AfeI and NotI and then inserted into the AfeI and NotI sites
of the pCBJESS-AfeI plasmid to create pCB8D1-2J,
pCB8D3-2J, and pCB8D4-2J for use in transient expres-
sion of chimeric VLPs of DENV-1, -3, and -4, respec-
tively. Plasmid constructs were designated according to the
percent of E protein-encoding sequence derived from the
DENV or JEV sequence. For example, the pCB8D1-2J
expression plasmid contains the 100% DENV-1 prM and a
recombinant E protein-encoding region consisting of the
amino-terminal 80% E sequence of DENV-1, designated
8D1, and the carboxy-terminal 20% E sequence of JEV,
designated as -2J.leotide sequencea
CTAGCGCTTTCCATCTGACCACCCGAGGGGGAGA
AAAGGCCTTGCCCAGCGTGCTTCCTTTCTTGAACCAGCTTAGT
CGAGCGCTTTCCATTTGACCACACGAGGGG
TCGCGGCCGCCGCTTGAACCATGACTCCTAGGTACAGTGTG
CTAGCGCTTTCCACTTGACTTCACGAGATGGAGA
AAAGGCCTTGCCCAGCGTGCTTCCCTTCTTGTACCAGTT
CTAGCGCTTTCCACTTGACTTCACGAGATGGAGAG
TCGCGGCCGCAGCTTGCACCACGGCTCCCAG
CTAGCGCTTTCACTTGTCAACAAGAGATGGC
AAAGGCCTTGCCCAGCGTACTCCCTTTCCTGAACCAATGGAGTGT
TTTCCTTGTCAACGAGAGAT
TCGCGGCCGCTTATGCATGAACTGTGAAACC
TTGGTACCGCCGCCGCCATGGGCAAG
TTCTCTTCCTGATGACATCCATGTTT
TCCTCTTCATCAGAAGGGGCCTGGAA
CTGGTCTCACGCAACGCATTGTCATT
GACTCTTCTTCAACGAAAGCCACACG
CCGGTCTCACGCAACGCATACTGTAAGCCGGAGCGACCAAC
CGGGTCTCATGCGTAGGAGTGGGGAA
GACCTAGGTTCACAATCAAGTGTTAA
font.
D.E. Purdy, G.-J.J. Chang / Virology 333 (2005) 239–250248The expression plasmids pCBD1, pCBD3, and pCBD4
contain the full-length prM/M and E protein-encoding
regions of DENV-1, -3, and -4, respectively. These plasmids
were amplified by RT-PCR using the appropriate primers
(Table 2) in a similar manner as described above and
were cloned directly into AfeI–NotI-digested pCBJESS-AfeI
vector.
For replacement of the carboxy-terminal stem-anchor
region of DENV-4 prM with the corresponding region of
JEV or DENV-2, primers (Table 2) were used to PCR
amplify the appropriate regions of pCB8D4-2J, pCDJE2-7,
and pCB8D2-2J-2-9-1. These PCR amplicons were
digested with EarI and/or BsaI, ligated at a molar ratio
of 1:1:1, and cloned into the pCBJESS-AfeI vector as
described above to create pCBD2prM8D4-2J and
pCBJprM8D4-2J which contained the stem-anchor region
of prM of DENV-2 and JEV, respectively. Additionally,
three additional amino acids of DENV-4 origin in the
pCBD2prM8D4-2J were converted to the corresponding
DENV-2 sequence (T5V, S8V, and A16T) to generate the
pCBD2M8D4-2J, using the QuikChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA), as per the
manufacturer’s recommended procedure. The primers used
for construction of pCBD2M8D4-2J are available upon
request.
Thirteen amino acids in the E-H1 and E-H2 amphi-
pathic a-helices region of E in pCB9D2-1J-4-3 differ from
the homologous region in pCB8D-2J-2-9-1 (Figs. 1 and 3,
Chang et al., 2003). Thus, these amino acids were
converted individually or in pairs from the DENV-2
sequence to the corresponding JEV sequence, respectively,
using the QuikChange site-directed mutagenesis kit.
Primers used in these reactions are also available upon
request.
Automated DNA sequencing was performed on CEQ
8000 Genetic Analysis System (Beckman Coulter, Full-
erton, CA) according to the manufacturer’s recommen-
ded procedure. The chimeric plasmids that had the
correct sequence were identified and used for expression
studies.
Electroporation of tissue culture cells with plasmid DNA
For transformation, tissue culture cells were grown to
90–100% confluence in 150-cm2 culture flasks, trypsi-
nized, and resuspended in ice-cold phosphate-buffered
saline (PBS) to a final density of 1.5  107 cells/ml. For
each reaction, 0.5 ml of this cell suspension was
electroporated with 30 Ag of plasmid DNA in a 0.4
cm electrode gap cuvette using a Bio-Rad Gene Pulser II
(Bio-Rad Laboratories, Hercules, CA) set at 250 V and
975 AF. Cells from each electroporation reaction were
seeded onto a single 75-cm2 culture flask containing 20
ml of growth medium. Each plasmid for expression
study was tested in triplicate. Tissue-culture medium was
harvested 48 h following electroporation and clarified bycentrifugation at 10,000 rpm for 10 min at 4 8C. The
Ag-ELISA was performed using flavivirus E-specific,
group-reactive monoclonal antibodies (MAb) 4G2 (Gen-
try et al., 1982) and horseradish peroxidase (HRP)-
conjugated 6B6C-1 (Roehrig et al., 1983; Jackson Immu-
nological Laboratories, Inc., West Grove, PA.) to capture
and detect secreted VLPs, respectively, as previously
described (Hunt et al., 2001). Clarified culture medium
from each electroporation reaction was tested by Ag-ELISA
in duplicate.
Western blot analysis
The DENV VLPs were concentrated and partially
purified from clarified tissue culture medium by ultra-
centrifugation at 19,000 rpm for 8–16 h in a Beckman
Coulter Type 19 rotor (Beckman Coulter) at 4 8C. The
pellet was resuspended in TN buffer (50 mM Tris, 100
mM NaCl, pH 7.5) to 1/50th the original volume,
aliquoted into 1-ml samples, and stored at 70 8C. DENV
VLPs and gradient purified virions were electrophoresed
under non-denaturing conditions on a NuPAGE 4–12%
Bis-Tris gradient gel in an XCell SureLock Mini-Cell
electrophoresis apparatus (Invitrogen Corp., Carlsbad, CA),
followed by electroblotting onto nitrocellulose membranes
using an XCell II Blot Module (Invitrogen Corp.). DENV
proteins were detected by Western blot using mouse
hyperimmune ascitic fluids (HIAF) against DENV-1
(Hawaii), DENV-2 (New Guinea C), DENV-3 (H-87),
and DENV-4 (H-241). All DENV-2 structural proteins
were individually identified using flavivirus group-reactive
MAb (4G2) specific for E protein, MAb (2H2) specific for
DENV-2 prM protein, antipeptide mouse serum against
DENV-2 M protein peptide (M protein aa 1–34), and MAb
(1A2A-1) specific for C protein.
Indirect immunofluorescence antibody assay
Transiently transformed CHO cells were seeded at
100 Al/well onto 96-well plates immediately following
electroporation and incubated 24 h. Adherent cells were
washed once with PBS and fixed with 3:1 acetone/PBS
(20 8C ) for 10 min. Fixed cells were washed twice with
PBS, air dried completely ~15–30 min, and then stored at
20 8C in a frost-free freezer until examination. MAb 4G2,
diluted 1:200 in PBS, was added at 100 Al/well and
incubated at 37 8C in a humidified chamber for 30 min.
Fluorescein isothiocyanate (FITC)-conjugated goat anti-
mouse IgG (Jackson Immunoresearch Laboratories) was
diluted 1:100 in PBS-Evans Blue (0.005% as counter-stain,
Sigma-Aldrich, St. Louis, MO), applied at 100 Al/well, and
incubated at 37 8C for 30 min. Wells were washed twice
with PBS, and 3 drops of mounting media from the Prolong
Antifade Kit (Molecular Probes, Eugene, OR) was added.
Fluorescent cells were examined using Zeiss KS 300
Imaging System (Carl Zeiss, Inc., Thornwood, NY), and E
D.E. Purdy, G.-J.J. Chang / Virology 333 (2005) 239–250 249protein localization pattern and fluorescent intensity were
recorded.
Alternatively, for preparation of microscopic slides
used in protein localization analysis, cell suspensions
from one 75-cm2 culture flask of electroporated cell
culture containing 20 ml growth medium were diluted 1:4
in growth medium, 1 ml was added to each well of a
Lab-Tek II Chamber slide (Nalge Nunc International,
Naperville, IL), and slides were incubated 48 h until cells
reached ~50–75% confluence. The tissue culture fluid was
then removed, cells were washed once with PBS and
fixed in 3:1 acetone/PBS as above. Slides were air dried
completely ~15–30 min then stored at 20 8C in a frost-
free freezer until examination. Rabbit serum against
DENV-2 prM/M and E proteins was obtained from rabbits
vaccinated with pCB8D2-2J-2-9-1 (G. J. Chang, unpub-
lished data). Three hundred microliters of diluted rabbit
serum (1:200 in StartingBlock (PBS) Blocking Buffer;
Pierce, Rockford, IL) was used to stain each chamber well
at RT for 1 h. Slides were washed three times with 1 ml
PBS. FITC-conjugated goat anti-rabbit IgG (Jackson
Immunoresearch Laboratories) was diluted 1:100 in
StartingBlock (PBS) Blocking Buffer and 400 Al was
added per well and incubated at RT for 1 h in the dark to
prevent loss of signal. Wells were washed 3 times with 1
ml PBS, the excess was drained, the well walls were
removed, and slides were briefly blotted dry. Cover glass
was affixed to slides with minimal volumes (~1 drop) of
mounting media from the Prolong Antifade Kit (Molec-
ular Probes).
Analysis of primary amino acid sequences
Helical wheel diagrams were constructed using BioEdit
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Secon-
dary structure prediction using PSI-BLAST PSSM matri-
ces was achieved with the YASPIN program using the
DSSP-trained neural network (http://ibivu.cs.vu.nl/programs/
yaspinwww/).Acknowledgments
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